LONDON (Reuters) – A single dose of the monkeypox vaccine provided 78% protection against the virus, according to British data released on Tuesday. Health officials said it was the strongest evidence to date of the efficacy of the monkeypox vaccine.
Monkeypox cases remain low, but the World Health Organization continues to classify the disease as a global health emergency, its highest level of alert.
A new analysis confirmed the data for the Bavarian Nordics. (BAVA.CO) Vaccine in England between July 4th and November. The UK Health Security Agency (UKHSA) announced on the 3rd.
According to UKHSA, one dose is 78% protective 14 days after vaccination, and a second dose is even more effective and long-lasting.
More than 55,000 doses of the vaccine have been delivered so far, according to officials.
Monkeypox, a relatively mild viral disease endemic in several countries in West and Central Africa, exploded around the world earlier this year.
Since then, there have been more than 80,000 cases worldwide, according to the US Centers for Disease Control and Prevention.
Reported by Sachin Ravikumar.Editing by Kate Holton
Our criteria: Thomson Reuters Trust Principles.